Human syncytiotrophoblast cell membranes prepared by differential ultracentrifugation were extracted with 3 M KCI, solubilized in 1% deoxycholate, and chromatographically separated into two peaks by passage through a column of Bio-Gel P-200. Previous reports from this laboratory have shown that the first peak (P1) is serologically the same as a group of trophoblast membrane antigens tentatively designated as TAI. Microgram amounts of P1 protein were found to completely inhibit the mixed lymphocyte culture (MLC) reaction but had no suppressive effect on lymphocyte responses to the lectins phytohemagglutinin or pokeweed mitogen. Control P1 membrane fractions identically prepared from human erythrocytes and liver-powder had no inhibitory effects on either MLC reactions or lymphocyte responses to mitogens. Doseresponse experiments with P1 from 10 different placentae showed total inhibition of MLC by all preparations when used between 25 and 50 ,ug/0.2-ml MLC mixture, but some P1 fractions inhibited significantly at much lower concentrations. Timed experiments revealed that MLC suppression was maximal when P1 was added within 12 hr after culture initiation and that no effect could be found with addition after 48 hr. We have previously shown that TA1 is a lymphocyte product of allogeneic responses, and the present results indicate that P1 proteins are themselves involved in the biology of lymphocyte responses to allogeneic cells. Pregnancy is one of the few natural circumstances in which a mixing of allogeneic cells occurs in vivo, and the presence of P1 proteins at the operational interface in the host-parasite relationship of human pregnancy suggests that this trophoblast membrane constituent is involved in the modulation of maternal allogeneic responses.
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Portions of the blastocyst that develop into the human embryo are sequestered from contact with maternal tissues by extraembryonic cells of fetal origin that, at maturity, are recognized as the amnion and placenta (1) . Much of the amnionic membrane is contiguous with maternal uterine decidua (2) , and the placenta is in contact with circumfluent maternal blood, thus providing for both anatomical contact and physiological exchange between genetically dissimilar tissues. In other circumstances of transplantation this would normally incite immunological rejection, yet the amnion and placental homografts grow unimpeded. Protection of the fetus from such rejection seems to be dependent on certain properties of the extraembryonic membranes, because mothers normally mount vigorous immunological responses to fetal allotypically incompatible antigens that leak free of these membranes into the maternal circulation (3) (4) (5) .
It is not presently known how extraembryonic tissues protect the embryo and fetus from damaging immunological reactions, but contemporary research suggests that more than one mechanism may be involved. For instance, syncytiotrophoblasts lack all presently known antigens of the major histocompatibility complex (MHC) (6) (7) (8) , thus denying the opportunity for conventional allogeneic recognition. Another unusual property of extraembryonic cells is the presence of membrane receptors for transferrin (9) ; invertebrates such as schistosomes have long employed binding of host proteins to escape immunosurveillance (10) . And finally, blocking antibodies have also been implicated in the transplantation immunobiology of the hostparasite relationship of human pregnancy (11, 12) .
Previous studies from this laboratory (13) with the use of heterologous anti-trophoblast sera have shown that trophoblast cell membrane antigens can be classified into at least two major groups, which we have tentatively designated as trophoblast antigens 1 (TAI), and trophoblast antigen 2 (TA2). The TA1 group is organ and species specific (14) and is identified on allogeneically stimulated but not on either resting or mitogenstimulated lymphotocytes (15) . Antisera raised to a chromatographically isolated trophoblast membrane fraction, known as peak 1 (P1), have been shown to contain anti-TA1 activity, and these antisera are able to inhibit the mixed lymphocyte culture (MLC) reaction (15, 16) 
MATERIALS AND METHODS
Trophoblast Membrane Preparations. Trophoblast microvilli were prepared from 10 placentae delivered of uncomplicated pregnancies by normal mothers and were collected and processed within 15 min of delivery. The organ was minced with scissors into 1-to 2-cm3 pieces and microvilli were prepared from these tissues according to the differential ultracentrifugation technique of Smith et al. (17) . The exclusive presence of microvilli in the ultracentrifuged pellet was confirmed by transmission electron microscropy. These microvilli contained large amounts of alkaline phosphatase (13) , suggesting that they were harvested from trophoblasts (13, 18) , and they lacked both HLA antigens and f2-microglobulin as determined by histocompatibility testing (19) and radioimmunoassay (8), thus indicating negligible contamination of the pellet with membranes from other placental cells. The microvilli were extracted by using a constant-motion rotor for 16 actions, 250,000 responder cells (0.1 ml) were cultured with 250,000 stimulator cells (0.1 ml) in flat-bottom microtiter trays (Falcon 3040). The lyophilized mitogens phytohemagglutinin (PHA, GIBCO) and pokeweed mitogen (PWM, GIBCO) were reconstituted and 0.025-ml samples of previously determined optimal stimulatory dilutions were added to cell cultures containing only responder cells. Cultures were plated in triplicate and incubated in an air/5% CO2 incubator for 5 days at 370C.
[3H]Thymidine (Schwarz/Mann) was added [2 ,gCi per well (1 Ci = 3.7 X 1010 becquerels)] and the cells were harvested 18 hr later in a multiple automated sample harvester (MASH II, Microbiological Associates, Walkersville, MD).
RESULTS
Several experiments were conducted to study the biological effects of trophoblast and control P1 membrane proteins on lymphocyte responses in vitro. The addition of 25 ,gg of P1 was sufficient to abolish all MLC reactivity (Fig. 1) . Identical amounts of P1 had no significant effect upon lymphocyte responses to previously determined optimal stimulatory doses of PHA or PWM (Fig. 1) . From 2). Trypan blue exclusion assays indicated that neither trophoblast nor control P1 preparations from erythrocytes or liver were cytotoxic. Addition of P1 cell membrane control proteins either was without affect or enhanced MLC (Fig. 3) , thus providing direct evidence that suppression is uniquely associated with trophoblast membranes. We have previously published indirect evidence in support of this concept, showing inhibition of MLC reactions with heterologous anti-P1 sera (15) . Dose-response experiments demonstrated a serial decrease in inhibition after dilution of P1 with culture media (Fig. 4) . There was, however, a slight variation in the suppressive ability of each P1 preparation, presumably representing technical variations in the isolation and purification of the membrane proteins. Nevertheless, all 10 trophoblast preparations were totally suppressive when used at between 25 and 50 pg. Indeed, in one instance, significant suppression was achieved with 4 pg (not shown). Timed studies showed P1 inhibition of MLC to be maximal when P1 was added some time during the first 12 hr of culture (Fig. 5) . Susceptibility to inhibition began to decline by 18 hr and was absent after 48 hr. These observations provide evidence that the suppressive effect of P1 on allogeneically stimulated lymphocytes depends on the time of administration, being undetectable if the P1 is added to an MLC after 48 hr of culture.
DISCUSSION
In this report we have shown that human trophoblast membrane proteins recovered on the first peak (P1) of chaotropeextracted, deoxycholate-solubilized, chromatographed trophoblast membranes are responsible for inhibiting allogeneic recognition reactions without altering lymphocyte responses to mitogens. P1 fractions isolated from control erythrocytes and liver tissue were ineffective when used in identical concentrations and culture conditions. Although the nature and biological mechanism responsible for trophoblast-lymphocyte interactions are unknown at present, evidence that sites for P1 or P1-like molecules become available on lymphocyte mem- Immunology: McIntyre and Faulk branes subsequent to allogeneic stimulation is shown both by immunofluorescence (16) and by anti-P1 inhibition of MLC reactions (15) . We have now shown that inhibition of MLCs by trophoblast membrane proteins is also both dose and time dependent, and that maximal suppression occurs during the first 12 hr of culture and disappears after 48 hr. It is presently unclear why both P1 and anti-Pi should impede allogeneic responses, but a rather similar phenomenon is found with antisera to insulin receptors: anti-receptor antibody and insulin have the same metabolic effects (21, 22) . Whether a P1 receptor is involved in the reactions we describe is not known, but the data do indicate that allogeneic stimulation either produces or exposes trophoblast crossregctive lymphocyte antigens that are involved in the biology of allogeneic reactions.
Mammalian lymphocytes are uncommonly required to express in vivo the phenomenon that in vitro is known as allogeneic recognition. However, during gestation, MHC-lacking syncytiotrophoblast membranes break away from chorionic villi and enter the maternal circulation via the uterine veins (23) . Taylor and Hancock (24) have provided in vitro data indicating that maternal lymphocytes are capable of mounting cytotoxic responses to these membranes, but the sensitizing antigens responsible for generating these reactions are not known. If maternal recognition of trophoblast antigens in vivo were potentially detrimental to the trophoblast, the placental bed is the logical anatomical site where such reactions must be modulated to ensure the integrity of the extraembryonic membranes. It thus seems more than coincidence that the membranes that form the operational interface between the mother and fetus in the host-parasite relationship of human pregnancy are exactly the cells that produce the MLC-inhibiting TA1 proteins. The concentration of trophoblast membranes in maternal blood is greatest within the intervillous spaces, and is progressively diluted as the blood passes into the uterine veins and inferior vena cava, thus creating a physiological circumstance in which maternal allogeneic reactions are inhibited only at the maternofetal interface. Our present data indicate that these trophoblast membrane proteins are effective inhibitors of allogeneic reactions in vitro and prompt us to suggest that the gene(s) responsible for this property has been amplified in trophoblasts through natural selection as placentation has evolved in mammals.
